Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Artisan Global Discovery 2025 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Artisan Global Discovery)

Primary Source Intelligence • Q1 2025 Letter Analysis

Artisan Global Discovery Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Artisan Global Discovery. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD-3.62%

YTD-3.62%

Annualized+11.5%

Positioning StanceConstructive

Market CapSMID Cap

GeographyGlobal

Digest Analysis

Quick Take

"Artisan Global Discovery underperformed in Q1 2025 as markets rotated from growth to value amid trade policy uncertainty and AI infrastructure concerns. Defense spending beneficiary Babcock and biotech Ascendis led contributors while AI-exposed names like MACOM detracted."

Executive Summary

Artisan Global Discovery Fund generated negative absolute returns and underperformed the MSCI AC World Small Mid Index in Q1 2025 as market leadership reversed course. After strong growth equity outperformance in 2023-2024, value led the way in Q1 amid a risk-off environment favoring lower volatility equities. The portfolio was hurt by overweight exposure to information technology, the worst performing sector, while positive security selection was driven by outperformance in IT and communication services. Top contributors included defense contractor Babcock benefiting from increasing defense budgets, Spotify continuing strong earnings momentum, and Ascendis Pharma's successful drug launch. Key detractors were West Pharmaceutical Services due to disappointing guidance, MACOM Technology Solutions impacted by AI infrastructure sentiment, and SAIA amid tariff concerns. The team initiated new positions in water solutions provider Aris and surgical robotics company PROCEPT while exiting Illumina and Wabtec. Looking forward, they remain cautious on macro activity due to trade policy volatility but are using market weakness to upgrade into highest conviction ideas with recession-resistant characteristics.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

75%

CautiousHigh

High Conviction (75%)

The manager demonstrates high conviction through specific investment decisions, detailed company analysis, and clear articulation of investment themes. They are actively making portfolio changes based on their views and maintaining positions in companies with strong fundamentals despite market volatility.

Growth Outlook

33%

BearishBullish

Bearish (33%)

The manager expresses caution about the macro environment, citing slowing US growth, consumer fatigue, persistent inflation, and rising recession risks. While they acknowledge some positive developments like defense spending increases, the overall market outlook is pessimistic with concerns about policy volatility and trade tensions.

Risk Appetite

43%

DefensiveAggressive

Balanced (43%)

The portfolio positioning shows moderate defensive adjustments with exits from some positions due to elevated valuations and tariff risks, while selectively adding to higher conviction ideas. The approach is cautious but not aggressively defensive, maintaining exposure while upgrading quality.

Capital Deployment

45%

De-riskingDeploying

Net Neutral (45%)

Capital deployment appears slightly negative with exits from Illumina and Wabtec, trims to several positions including Spotify and SAIA, while adding new positions in Aris and PROCEPT. The net activity suggests modest de-risking while selectively upgrading portfolio quality.

Forward Guidance

38%

CautiousExpansionary

Neutral (38%)

Forward guidance emphasizes caution on macroeconomic activity and monitoring for additional policy wildcards. The team is preparing for potential economic slowdown while selectively deploying capital, indicating a defensive but opportunistic stance.

Language Signal

40%

BearishBullish

Balanced (40%)

Language contains more risk-focused terms like 'uncertainty,' 'volatility,' 'recession fears,' and 'caution' than opportunity-focused language. While some positive themes are discussed, the net balance of directional language skews toward risk awareness and defensive positioning.

Perceived Risk

70%

Low RiskElevated

Elevated Risk (70%)

The manager perceives elevated risk from multiple sources including trade policy volatility, slowing economic growth, persistent inflation, and rising recession probability. Specific concerns about tariff impacts and policy uncertainty indicate high awareness of systemic risks.

Opportunity Density

45%

ScarceAbundant

Selective (45%)

Opportunity density appears moderate with selective opportunities in specific themes like defense spending, biotechnology, and water solutions. The manager is finding attractive valuations due to market volatility but acknowledges the challenging macro environment limits broad opportunities.

Time Horizon

80%

Short-TermLong-Term

Decade+ (80%)

The investment approach emphasizes long-term profit cycles, franchise characteristics, and multi-year themes like defense spending increases and drug launches. The focus on companies with durable business models and patient capital deployment suggests a long-term investment horizon.